{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T05:47:56Z","timestamp":1777787276690,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFD0500902"],"award-info":[{"award-number":["2017YFD0500902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFE0204100"],"award-info":[{"award-number":["2016YFE0204100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.molimm.2019.07.021","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T05:38:18Z","timestamp":1564810698000},"page":"226-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Antiviral activity of merimepodib against foot and mouth disease virus in vitro and in vivo"],"prefix":"10.1016","volume":"114","author":[{"given":"Shi-fang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-jiao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-jun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-guang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-yun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.07.021_bib0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.mi.22.100168.001221","article-title":"Foot-and-mouth disease","volume":"22","author":"Bachrach","year":"1968","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2019.07.021_bib0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Infectious disease. Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science."},{"key":"10.1016\/j.molimm.2019.07.021_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014621","article-title":"Rescue of foot-and-mouth disease viruses that are pathogenic for cattle from preserved viral RNA samples","volume":"6","author":"Belsham","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.07.021_bib0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2011.02.023","article-title":"Antiviral activity of bovine type III interferon against foot-and-mouth disease virus","volume":"413","author":"Diaz-San","year":"2011","journal-title":"Virology."},{"key":"10.1016\/j.molimm.2019.07.021_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0168-1702(02)00259-9","article-title":"Evolution of foot-and-mouth disease virus","volume":"91","author":"Domingo","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.molimm.2019.07.021_bib0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature."},{"key":"10.1016\/j.molimm.2019.07.021_bib0035","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.vaccine.2005.07.043","article-title":"Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response","volume":"23","author":"Golde","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.07.021_bib0040","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molimm.2019.07.021_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.molimm.2019.07.021_bib0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2012.09.009","article-title":"Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-alpha and antiviral agents","volume":"96","author":"Kim","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.molimm.2019.07.021_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-1702(02)00260-5","article-title":"Molecular epidemiology of foot-and-mouth disease virus","volume":"91","author":"Knowles","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.molimm.2019.07.021_bib0060","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/molecules24091723","article-title":"In vitro and in vivo antiviral activity of mizoribine against foot-and-Mouth disease virus","volume":"24","author":"Li","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.molimm.2019.07.021_bib0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jhep.2007.03.028","article-title":"Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C","volume":"47","author":"Marcellin","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molimm.2019.07.021_bib0070","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","article-title":"Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon","volume":"44","author":"Markland","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2019.07.021_bib0075","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.02775-06","article-title":"Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons","volume":"81","author":"Moraes","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2019.07.021_bib0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2011.05.006","article-title":"Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus","volume":"91","author":"Olschlager","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.molimm.2019.07.021_bib0085","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.23204","article-title":"Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders","volume":"50","author":"Rustgi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.molimm.2019.07.021_bib0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2017.11.004","article-title":"Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens","volume":"149","author":"Tong","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.molimm.2019.07.021_bib0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2017.01.018","article-title":"Antiviral activity of ovine interferon tau 4 against foot-and-mouth disease virus","volume":"143","author":"Usharani","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.molimm.2019.07.021_bib0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2015.12.006","article-title":"Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses","volume":"126","author":"Westover","year":"2016","journal-title":"Antiviral Res."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019301774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019301774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:50:15Z","timestamp":1777492215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019301774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":20,"alternative-id":["S0161589019301774"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.07.021","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activity of merimepodib against foot and mouth disease virus in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}